[go: up one dir, main page]

AU2002351739A1 - Solid dose micro implant - Google Patents

Solid dose micro implant

Info

Publication number
AU2002351739A1
AU2002351739A1 AU2002351739A AU2002351739A AU2002351739A1 AU 2002351739 A1 AU2002351739 A1 AU 2002351739A1 AU 2002351739 A AU2002351739 A AU 2002351739A AU 2002351739 A AU2002351739 A AU 2002351739A AU 2002351739 A1 AU2002351739 A1 AU 2002351739A1
Authority
AU
Australia
Prior art keywords
solid dose
micro implant
dose micro
implant
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351739A
Other languages
English (en)
Inventor
Henrik Egesborg Hansen
Thomas Buch Rasmussen
Mads Christian Sabra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2002351739A1 publication Critical patent/AU2002351739A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002351739A 2001-12-18 2002-12-17 Solid dose micro implant Abandoned AU2002351739A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101901 2001-12-18
DKPA200101901 2001-12-18
PCT/DK2002/000865 WO2003051328A1 (fr) 2001-12-18 2002-12-17 Micro implant a dose solide

Publications (1)

Publication Number Publication Date
AU2002351739A1 true AU2002351739A1 (en) 2003-06-30

Family

ID=8160907

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351739A Abandoned AU2002351739A1 (en) 2001-12-18 2002-12-17 Solid dose micro implant

Country Status (4)

Country Link
EP (1) EP1458352A1 (fr)
JP (2) JP4615862B2 (fr)
AU (1) AU2002351739A1 (fr)
WO (1) WO2003051328A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US20070116738A1 (en) * 2003-06-26 2007-05-24 Patrice Mauriac Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
AU2004292957C1 (en) * 2003-11-13 2011-04-28 Eyepoint Pharmaceuticals Us, Inc. Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US7846361B2 (en) 2006-07-20 2010-12-07 Orbusneich Medical, Inc. Bioabsorbable polymeric composition for a medical device
WO2008070304A2 (fr) 2006-10-20 2008-06-12 Orbusneich Medical, Inc. Composition polymère bioabsorbable et fond de dispositif médical
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
EP1917971A1 (fr) * 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Préparations à libération prolongée comprenant des polymères à poids moléculaire très bas
GB2446780A (en) * 2007-02-22 2008-08-27 Glide Pharmaceutical Technolog An elongate parenteral injection body having an injection point of angle 10 to 40 degrees.
AU2014253541B2 (en) * 2007-02-22 2016-07-28 Glide Pharmaceutical Technologies Limited Solid pharmaceutical and vaccine dose
GB2545880A (en) 2015-10-20 2017-07-05 Glide Pharmaceutical Tech Ltd Solid formulation
AU2018282874B2 (en) * 2017-06-13 2024-05-16 Eyepoint Pharmaceuticals, Inc Bioerodible drug delivery devices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
EP0542915A1 (fr) * 1990-08-09 1993-05-26 Endocon, Inc. Systeme d'administration de medicaments multiples
RO112810B1 (ro) * 1991-12-27 1998-01-30 Merck & Co Inc Dispozitiv de eliberare controlata a unui medicament sub forma unei dispersii
WO1993017662A1 (fr) * 1992-03-02 1993-09-16 Daratech Pty. Ltd. Implants ameliores
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤
WO2000062759A1 (fr) * 1999-04-16 2000-10-26 Novo Nordisk A/S Formulation pharmaceutique seche et moulable

Also Published As

Publication number Publication date
EP1458352A1 (fr) 2004-09-22
JP4615862B2 (ja) 2011-01-19
JP2005517651A (ja) 2005-06-16
JP2010280709A (ja) 2010-12-16
WO2003051328A1 (fr) 2003-06-26

Similar Documents

Publication Publication Date Title
AU2002328762A1 (en) Osteophilic implants
AUPR851601A0 (en) Auditory midbrain implant
AU9517301A (en) Implant
AUPR457901A0 (en) Acetabular prosthesis assembly
AU2001263841A1 (en) Implant
AU2001254786A1 (en) Medical implant
AU2001270206A1 (en) Dental implant
AU2002253039A1 (en) Tramadol-based medicament
AUPR526301A0 (en) Prosthetic implant
AU2001272189A1 (en) Configuration of implanted devices
AU2002351739A1 (en) Solid dose micro implant
AU2002359715A1 (en) Implant coatings
GB0319495D0 (en) An implant
AU2002319650A1 (en) Defibrillators
AU2002321019A1 (en) Bone implant
AU2002210298A1 (en) Dental implant
AU2002367158A1 (en) Expandable dental implant
AUPR247601A0 (en) Cochlear implant communicator
AU2002306283A1 (en) Implant
AU2002328991A1 (en) Prosthesis
AU2002363760A1 (en) Medical implant
AU2002231555A1 (en) Medical implant
AU2002244609A1 (en) Dental implant
AU2001279541B2 (en) Implanted hearing aid
AU2002309547A1 (en) Xe preamorphizing implantation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase